The market expansion and approvals update at least got some decent national coverage for those who did not see:
https://www.theaustralian.com.au/business/*/content/orthocell-ramps-up-global-expansion-of-marketleading-regenerative-medicine-products/news-story/cdb7ec3d821b19b780c2dcca7c8b4299
The business is improving (the much hearalded 30% revenue growth does indeed need to accelerate) and the foundations for expansion there, but the casual effects of media coverage in smaller capped stocks not to be underestimated. I think OCC featured once before in the Fin Review from memory:
https://www.copyright link/companies/healthcare-and-fitness/the-key-to-this-biotech-s-tilt-at-us-fortune-is-pure-pigs-20231030-p5eg4k
Another would be nice for share price progression....
The market expansion and approvals update at least got some...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $24.44K | 62.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 649 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |